The Pequot Compact Puts Connecticut's Equity System Under Pressure From Both Sides
Connecticut’s adult-use cannabis program was sold as “responsible and equitable.” But two records now point to a deeper structural problem.
Part of Public Records, FOIA and Transparency
Analysis. This piece interprets reported facts. The underlying records are linked in the sources below.
CT CannaTimes Editor - 6.25.2026
Connecticut’s adult-use cannabis program was sold as “responsible and equitable.” But two records now point to a deeper structural problem.
In federal court, Brant Smith is challenging Connecticut’s social-equity licensing regime as an unconstitutional barrier to market entry. At the same time, Governor Ned Lamont has signed a compact with the Mashantucket Pequot Tribal Nation that creates a parallel cannabis channel outside the ordinary lottery, fee, tax, and enforcement structure imposed on everyone else.
The issue is not tribal sovereignty itself. The Mashantucket Pequot Tribe is a sovereign government, and any fair story must recognize that. The issue is what Connecticut chose to negotiate: a cannabis market pathway that can interact with state licensees, avoid state and municipal taxes, bypass lottery and fee requirements for key license categories, and operate under health-and-safety standards the state cannot directly enforce.
That matters because Connecticut’s cannabis taxes are supposed to fund repair. The Social Equity and Innovation Fund was built as the fiscal engine of cannabis justice. But under the compact, tribal cannabis sales are taxed by the Tribe, not the state. Consumers may pay a tax equivalent to the state’s cannabis tax, but the money does not flow into Connecticut’s equity fund.
At the same time, the compact inherits Connecticut’s product-safety standards while moving enforcement largely outside DCP’s hands. The Tribe must “meet or exceed” state standards, including testing rules, but DCP does not retain normal inspection, reporting, notice, or enforcement authority over those standards on tribal land. The result is a consumer-protection blind spot: products may be tested in the same lab universe, but the public visibility and enforcement chain may not be the same.
That is the Connecticut cannabis contradiction: the state defends a costly, delayed, litigated equity licensing gauntlet in court … while opening a separate sovereign lane that avoids much of that gauntlet entirely.
The question for regulators is simple: if equity, transparency, tax repair, and product safety are the pillars of Connecticut cannabis policy, why did the state sign a compact that weakens all four at once?
This story was originally published by Connecticut CannaTimes on Facebook on June 25, 2026 and was migrated to this website on October 16, 2026. The publication date above is the original date.
More in Public Records, FOIA and Transparency
The full investigation- DCP Faces October 26 Deadline on Testing Transparency and Patient Oversight PetitionOctober 8, 2026 · Patients & Testing
- Lamont Administration Worked on Tribal Compact for 20 Months; Industry Got 45 Minutes' NoticeOctober 2, 2026 · Regulators
- Connecticut Has Quietly Tested Hundreds of Cannabis Products. Now It Is Expanding Its Reference LabSeptember 23, 2026 · Patients & Testing

